Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

Frank Trudo,1 David M Kern,2 Jill R Davis,1 Ozgur Tunceli,2 Siting Zhou,2 Emma L Graham,3 Charlie Strange,4 Setareh A Williams1 1AstraZeneca Pharmaceuticals LP, 2HealthCore, Inc., Wilmington, DE, USA; 3AstraZeneca Pharmaceuticals LP, Alderley Park, Cheshire, UK; 4Division of Pulmonary and Critical...

Full description

Bibliographic Details
Main Authors:	Trudo F, Kern DM, Davis JR, Tunceli O, Zhou S, Graham EL, Strange C, Williams SA
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-09-01
Series:	International Journal of COPD
Online Access:	https://www.dovepress.com/comparative-effectiveness-of-budesonideformoterol-combination-and-tiot-peer-reviewed-article-COPD

Similar Items

A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease
by: Kern DM, et al.
Published: (2014-07-01)

Budesonide/formoterol combination in COPD: a US perspective
by: Amir Sharafkhaneh, et al.
Published: (2010-10-01)

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
by: Kalhan R, et al.
Published: (2021-04-01)

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
by: Tang B, et al.
Published: (2019-04-01)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
by: Calverley PM, et al.
Published: (2016-12-01)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
by: Moitra S, et al.
Published: (2015-04-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
by: Nicola A. Hanania, et al.
Published: (2020-04-01)

Budesonide/formoterol enhances the expression of pro Surfactant Protein-B in lungs of COPD patients.
by: Soo Jung Um, et al.
Published: (2013-01-01)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
by: Anthony D. D’Urzo, et al.
Published: (2019-05-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Controlled trial of budesonide–formoterol as needed for mild asthma
by: Beasley, R, et al.
Published: (2019)

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD
by: Martyn R. Partridge, et al.
Published: (2009-08-01)

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
by: Mantero M, et al.
Published: (2018-07-01)

Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study
by: Roberto Walter Dal Negro, et al.
Published: (2012-04-01)

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
by: Bafadhel, M, et al.
Published: (2018)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
by: Chiyohiko Shindoh, et al.
Published: (2012-01-01)

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
by: Andersson Eva, et al.
Published: (2009-02-01)

Inhibition of granulocyte migration by tiotropium bromide
by: Randerath Winfried J, et al.
Published: (2011-02-01)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
by: Perrone V, et al.
Published: (2017-01-01)

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
by: Wang C, et al.
Published: (2017-12-01)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study
by: Edward C. Portillo, et al.
Published: (2023-04-01)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
by: David B. Price, et al.
Published: (2018-06-01)

Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
by: Onkardeep Kaur, et al.
Published: (2023-01-01)

Efficacy of indacaterol 75 &micro;g versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
by: Cope S, et al.
Published: (2012-07-01)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
by: Strange C, et al.
Published: (2023-10-01)

Tiotropium - Advancing the treatment of COPD
by: Chambers, S, et al.
Published: (2008)

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study
by: Edward M. Kerwin, et al.
Published: (2019-07-01)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-05-01)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
by: Arun Jenish J, et al.
Published: (2012-03-01)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
by: Fang Yi, et al.
Published: (2022-10-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
by: Peter N Huynh, et al.
Published: (2010-02-01)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
by: Derom E, et al.
Published: (2016-12-01)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-06-01)